Literature DB >> 24814920

The role of CDX2 in inflammatory bowel disease.

Mehmet Coskun1.   

Abstract

BACKGROUND: High levels of pro-inflammatory cytokines are present in the gut of patients with inflammatory bowel disease (IBD) and have a crucial role in the dysfunction of mucosal homeostasis. Caudal-related homeobox transcription factor 2 (CDX2) is an essential regulator of intestinal epithelium homeostasis. When expressed, CDX2 modulates a diverse set of processes, including cell proliferation and differentiation, and cell adhesion and migration. In addition to these critical cellular processes, there is increasing indications (such as involvement in pro-inflammatory pathways and regulation of genes of importance for intestinal homeostasis) linking CDX2 to intestinal inflammation. AIM: The overall objective of this PhD thesis was to explore the role of CDX2 in the colonic epithelium of patients with IBD and to investigate the impact of pro-inflammatory pathways on the expression of CDX2 and its target genes.
METHODS: Initially, a literature research was conducted to review the importance of CDX2 in epithelial homeostasis and its potential role in mucosal inflammation. Expression of CDX2 was measured in colonic biopsies of patients with IBD, and the effects of pro-inflammatory cytokines and anti-TNF-α treatment (infliximab) were examined in Caco-2 cells. The role of CDX2 in the transcriptional regulation of MEP1A and the β-catenin degradation complex genes APC, AXIN2, and GSK3β were investigated in Caco-2 cells. Finally, the intracellular signalling pathways involved in the TNF-α-mediated down-regulation of CDX2 were investigated.
RESULTS: The expression of CDX2 was decreased in the epithelium of patients with ulcerative colitis (UC), and the expression was inversely correlated with the level of TNF-α. The endogenous expression of CDX2 in Caco-2 cells was decreased by TNF-α through NF-κB and p38 MAPK pathways. High levels of TNF-α affected the expression of CDX2 target genes and reduced the binding of CDX2 to gene regulatory regions of these targets in Caco-2 cells. Finally, TNF-α increased the expression of well-known Wnt target genes.
CONCLUSIONS: These findings indicate that the CDX2 expression is decreased in UC, and moreover, the studies in Caco-2 cells have shed light on some of the molecular pathways of importance in the inhibitory effect of TNF-α. In addition, these studies have provided novel insight into the CDX2-mediated regulation of genes involved in the β-catenin degradation complex and in response to the pro-inflammatory cytokine, TNF-α. In particular, these findings indicate that CDX2 is involved in the crosstalk between TNF-α and the Wnt signalling pathway, which might be of importance in understanding the link between intestinal inflammation and tumourigenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24814920

Source DB:  PubMed          Journal:  Dan Med J        ISSN: 2245-1919            Impact factor:   1.240


  10 in total

1.  CDX2 upregulates SLC26A3 gene expression in intestinal epithelial cells.

Authors:  Ishita Chatterjee; Anoop Kumar; Rosa María Castilla-Madrigal; Oscar Pellon-Cardenas; Ravinder K Gill; Waddah A Alrefai; Alip Borthakur; Michael Verzi; Pradeep K Dudeja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-06-01       Impact factor: 4.052

2.  Association of hepatocyte-derived growth factor receptor/caudal type homeobox 2 co-expression with mucosal regeneration in active ulcerative colitis.

Authors:  Ferenc Sipos; Miklós Constantinovits; Gábor Valcz; Zsolt Tulassay; Györgyi Műzes
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

Review 3.  Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics.

Authors:  Konstantinos H Katsanos; Konstantinos A Papadakis
Journal:  Gut Liver       Date:  2017-07-15       Impact factor: 4.519

4.  Gene Signature-Based Approach Identified MEK1/2 as a Potential Target Associated With Relapse After Anti-TNFα Treatment for Crohn's Disease.

Authors:  Kanae Gamo; Yuumi Okuzono; Masato Yabuki; Takashi Ochi; Kyoko Sugimura; Yosuke Sato; Masaki Sagara; Hiroki Hayashi; Yoshimasa Ishimura; Yutaka Nishimoto; Yusuke Murakawa; Zenyu Shiokawa; Masayuki Gotoh; Takahiro Miyazaki; Yukihiko Ebisuno
Journal:  Inflamm Bowel Dis       Date:  2018-05-18       Impact factor: 5.325

5.  Induced organoids derived from patients with ulcerative colitis recapitulate colitic reactivity.

Authors:  Samaneh K Sarvestani; Steven Signs; Bo Hu; Yunku Yeu; Hao Feng; Ying Ni; David R Hill; Robert C Fisher; Sylvain Ferrandon; Reece K DeHaan; Jennifer Stiene; Michael Cruise; Tae Hyun Hwang; Xiling Shen; Jason R Spence; Emina H Huang
Journal:  Nat Commun       Date:  2021-01-11       Impact factor: 14.919

6.  Artificial Neural Network Analysis-Based Immune-Related Signatures of Primary Non-Response to Infliximab in Patients With Ulcerative Colitis.

Authors:  Xuanfu Chen; Lingjuan Jiang; Wei Han; Xiaoyin Bai; Gechong Ruan; Mingyue Guo; Runing Zhou; Haozheng Liang; Hong Yang; Jiaming Qian
Journal:  Front Immunol       Date:  2021-12-21       Impact factor: 7.561

7.  Pluripotency of periodontal ligament and dental pulp cells is induced by intercellular communication via the CDX2/Oct-4/Sox2 pathway.

Authors:  Yaru Wei; Zhengjun Peng
Journal:  Ann Transl Med       Date:  2022-08

8.  Intestinal regulation of suppression of tumorigenicity 14 (ST14) and serine peptidase inhibitor, Kunitz type -1 (SPINT1) by transcription factor CDX2.

Authors:  E Thomas Danielsen; Anders Krüger Olsen; Mehmet Coskun; Annika W Nonboe; Sylvester Larsen; Katja Dahlgaard; Eric Paul Bennett; Cathy Mitchelmore; Lotte Katrine Vogel; Jesper Thorvald Troelsen
Journal:  Sci Rep       Date:  2018-08-07       Impact factor: 4.379

9.  Cdx2 regulates immune cell infiltration in the intestine.

Authors:  Simon Chewchuk; Sanzida Jahan; David Lohnes
Journal:  Sci Rep       Date:  2021-08-04       Impact factor: 4.379

10.  Exosomal CagA from Helicobacter pylori aggravates intestinal epithelium barrier dysfunction in chronic colitis by facilitating Claudin-2 expression.

Authors:  Yinjie Guo; Canxia Xu; Renjie Gong; Tingzi Hu; Xue Zhang; Xiaoran Xie; Jingshu Chi; Huan Li; Xiujuan Xia; Xiaoming Liu
Journal:  Gut Pathog       Date:  2022-03-24       Impact factor: 4.181

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.